Novo Nordisk (NVO) Q2 2023 Earnings Call Transcript : vimars

NVO earnings call for the period ending June 30, 2023.

Related Keywords

China , Germany , Japan , United States , Norway , Denmark , Danish , American , Chinese , Kerry Holford , Peter Welford , Simon Baker Redburn , Inversago Pharma , Peter Verdult , Mike Nedelcovych , Karsten Munk Knudsen , Novo Nordisk , Martin Holst Lange , Pete Verdult , Florent Cespedes , Camilla Sylvest , Harry Sephton , Peter Verdult Citi , Richard Vosser Jpmorgan , Florent Cespedes Societe Generale , Societe Generale , Kerry Holford Berenberg , Michael Novod Nordea , Richard Parkes Exane , Richard Vosser , Simon Baker , Lars Fruergaard Jorgensen , Daniel Bohsen , Richard Parkes , Sachin Jain , Michael Novod , Michael Leuchten , Martin Parkhoi , America Merrill Lynch , Peter Welford Jefferies , Doug Langa , Nordea , Credit Suisse , Sachin Jain Bank , Head Of Development , Barclays , Company Analyst , American Heart Association Congress , Corporate Affairs , American Heart Association , Citigroup , North America , Karsten Munk , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , Vice President , Commercial Strategy , Forma Therapeutics , Enskilda Banken , Emily Field , American Heart , Capital Markets , Investor Relations , Redburn Partners , Berenberg Capital ,